Limb-Girdle Muscular Dystrophy Guide for Families, Caregivers & HCPs - Access the webinar registration
The neuromuscular junction in Sarcoglycanopathies - Access the webinar registration
A Guide for Families with LGMD
International LGMD Conference 2025
Patient stem cells (iPSCs) and their role in LGMDs treatment - Access the webinar registration
Ongoing clinical trials on Limb-Girdle Muscular Dystrophies - Access the webinar registration
SAVE AHMED AND HIS FAMILY FROM GAZA
ITALIAN Minister of Disability'S VISIT FOR NEW GFB HEADQUARTERS
A Trial to Learn About A Gene Therapy as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)
Gene therapy for LGMD2E/R4: phase 1/2 trial results
GFB INTERVIEW ON SPAZIO LIBERO | DEC. 12, 2023
THIRD IBEROAMERICAN LGMD DAY
INTERNATIONAL LGMD CONFERENCE 2023
National Conference on LGMD of the Rare Academy, National Centre for Rare Diseases (CNMR) of the Russian Federation
INDIVIDUAL WITH LGMD: Jacob
GFB AT THE EAMDA 2023 CONGRESS
ATA-200, Atamyo Therapeutics’ Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type 2C/R5...
what muscular dystrophy did to me...?
INDIVIDUAL WITH LGMD: PETER
PHOTOS AND VIDEOS | 10 YEARS OF GFB EVENT
GFB SCIENTIFIC WEBINAR RECORDING | 24TH MARCH 2023
Sarepta Therapeutics Announces Initiation of VOYAGENE, a Clinical Study of SRP-9003 for the Treatment of LGMD2E/R4
Sarepta Therapeutics JOURNEY PROJECT update
GFB SCIENTIFIC WEBINAR RECORDING | 10th february 2023
GFB SCIENTIFIC WEBINAR RECORDING | 25TH NOVEMBER 2022
GFB SCIENTIFIC WEBINAR RECORDING | 15TH NOVEMBER 2022
GFB AT THE AIM CONGRESS IN MATERA, ITALY
Natural history study journey in europe
GFB AT THE WMS CONGRESS IN CANADA
The GFB group of arabic patients is here
The GFB group of Russian-speaking patients is here
Called to action when your son has LGMD
A story of inner strength: Raising two kids with LGMD
GFB at the Myology 2022 congress
INDIVIDUAL WITH LGMD: Arthur
Making the best of an early LGMD diagnosis
join the pfdd event on the 23rd september
GFB E-POSTER PRESENTATION AT THE ICNMD 2022 CONGRESS
2022 LGMD Global Advocacy Summit
QUALITY PROJECT: 200 COMPLETED QUESTIONNAIRES
GFB ON SPAZIO LIBERO - HOPE FOR RESEARCH
INDIVIDUAL WITH LGMD: Osman
Teaching what she knows: the story of daneal
GFB and the situation of patients in Ukraine
LET'S PARTICIPATE AT THE RARE DISEASE DAY 2022
WATCH THE GFB WEBINAR ON THE NATURAL HISTORY STUDY JOURNEY
GFB'S NATURAL HISTORY STUDY
JOURNEY NATURAL HISTORY STUDY
GFB SCIENTIFIC WEBINAR FOR LGMD PATIENTS: 25TH NOVEMBER 2022
Dr. Yvan Torrente receives the "Neurologist of the Year 2021" award
GFB SCIENTIFIC WEBINAR FOR LGMD PATIENTS: 15TH NOVEMBER 2022
GFB SPOT - INTERNATIONAL LGMD CONFERENCE 2021
LGMD INTERNATIONAL CONFERENCE 2021 VIDEOS
The early days after an LGMD diagnosis
GFB INTERVIEW AT THE ITALIAN NATIONAL TELEVISION
Sarepta Therapeutics’ Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E Shows Sustained Expression and Functional Improvements 2 Years After Administration
the story of shanna who has LGMD2C (or LGMDR5)
the story of johann: Patient with α-Sarcoglycanopathy (LGMD-R3)
The Story of Apollo, Patient with Gamma-Sarcoglycanopathy (LGMD-R5)
ATAMYO THERAPEUTICS: THE NEW WEBSITE IS NOW ONLINE
LET'S PARTICIPATE WITH GFB AT THE RARE DISEASE DAY - FEBRUARY 28th 2021
sarepta community bulletin: covid-19 vaccination and gene therapy
parent project usa: watch covid-19 vaccination & duchenne what you need to know
MANDINE: innocence in combat
Matis, silent warrior with LGMD2D (or LGMDR3)
Mélanie, explorer of the world and of science
The Story of Arthur with Gamma-Sarcoglycanopathy
Genethon's first LGMD biotech
international webinar about LGMD and gene therapy
Sarepta Therapeutics Investigational Gene Therapy SRP-9003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2E
The man investigating his rare disease: "There are many questions to be answered"– Carles Interview
CHRIS CALABRESE STORY AND HIS YOUTUBE CHANNEL
patient-led listening sessions summaries: LGMD
PONTI TELEMEDICINE PROJECT
MUSCLE DIVERSITY THE PROJECT BY CARLES SANCHEZ RIERA
SAREPTA THERAPEUTICS HAS ANNOUNCED POSITIVE DATA FOR SRP-9003 GENE THERAPY TRIAL
EMBRACING THE JOURNEY WITH LGMD: KATHERINE
Building an LGMD support network: Rania
One family's diagnostic journey to LGMD: Ben and Nikki
When LGMD is misdiagnosed: Chris
THE SIGN AND SYMTOMPS THAT POINTED TO LGMD: AUSTIN
